NICE Drugs Policy and the Elderly (NHS Choices)

Summary

News of a Department of Health consultation, which involves asking the National Institute for Health and Care Excellence (NICE) to consider “wider societal benefits” (in addition to the burden of illness and the impact a disease has on patients) when approving new drugs, has led to media speculation that vulnerable groups such as the elderly could be deprived treatments available to more economically active citizens.

These fears of older people missing-out on new / expensive treatments because they may be assessed as not to contributing sufficiently to society have been dismissed as scaremongering. Such age discrimination would run counter to the NHS Constitution.

Full Text Link

Reference

NICE drugs policy for the elderly is unchanged. London: NHS Choices Behind the Headlines, February 18th 2014.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, Management of Condition, National, NHS, NHS Digital (Previously NHS Choices), NICE Guidelines, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.